We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current VIV market cap is 385.94k. The company's latest EPS is CAD -0.0786 and P/E is 0.00.
| Year End 31 October 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 1.07M | 977k | 1.78M | 1.47M | 989k |
| Operating Income | -4.4M | -3.94M | -879k | -1.4M | -1.53M |
| Net Income | -4.83M | -4.84M | -4.75M | -6.39M | -6.07M |
| Year End 31 October 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 3.11M | 1.89M | 2.18M | 3.48M | 1.37M |
| Total Liabilities | 3.02M | 5.14M | 6.94M | 7.43M | 7.35M |
| Total Equity | 94k | -3.26M | -4.77M | -3.95M | -5.98M |
| Year End 31 October 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -3.81M | -3.52M | -3.34M | -4.6M | -3.12M |
| Investing | -69k | -109k | -44k | -9k | N/A |
| Financing | 4.48M | 2.51M | 2.96M | 5.35M | 2M |
| Market Cap | 385.94k |
| Price to Earnings Ratio | 0.00 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 77.19M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0 (0%) |
| Company Name | Avivagen Inc |
| Address |
100 sussex drive ottawa, ontario K1A 0R6 |
| Website | https://www.avivagen.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
